Determinant Factors of the Direct Medical Costs Associated with Genotype 1 Hepatitis C Infection in Treatment-Experienced Patients
Crossref DOI link: https://doi.org/10.1007/s40268-015-0109-5
Published Online: 2015-09-28
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Akpo, Essè Ifèbi Hervé
Sbarigia, Urbano
Wan, George
Kleintjens, Joris
Funding for this research was provided by:
Janssen Pharmaceutica
License valid from 2015-09-28